Literature DB >> 6863094

Pulmonary effects of ozone exposure during exercise: dose-response characteristics.

W F McDonnell, D H Horstman, M J Hazucha, E Seal, E D Haak, S A Salaam, D E House.   

Abstract

Because minimal data are available regarding the pulmonary effects of ozone (O3) at levels less than 0.27 ppm, six groups of healthy young males were exposed for 2.5 h to one of the following O3 concentrations: 0.0, 0.12, 0.18, 0.24, 0.30, or 0.40 ppm. Fifteen-minute periods of rest and exercise (65 l/min minute ventilation) were alternated during the first 2 h of exposure. Coughing was observed at all levels of O3 exposure. Small changes in forced-expiratory spirometric variables [forced vital capacity (FVC), forced expiratory volume in 1 s, and mean expiratory flow rate between 25 and 75% FVC] were observed at 0.12 and 0.18 ppm O3, and larger changes were found at O3 levels greater than or equal to 0.24 ppm. Changes in tidal volume and respiratory frequency during exercise, specific airway resistance, the presence of pain on deep inspiration, and shortness of breath occurred at O3 levels greater than or equal to 0.24 ppm. In conclusion, pulmonary effects of O3 were observed at levels much lower than that for which these effects have been previously described. Stimulation of airway receptors is probably the mechanism responsible for the majority of observed changes; however, the existence of a second mechanism of action is postulated.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6863094     DOI: 10.1152/jappl.1983.54.5.1345

Source DB:  PubMed          Journal:  J Appl Physiol Respir Environ Exerc Physiol        ISSN: 0161-7567


  32 in total

1.  Repeated exposure to ozone increases alveolar macrophage recruitment into asthmatic airways.

Authors:  Mehrdad Arjomandi; Allyson Witten; Emilio Abbritti; Kurt Reintjes; Isabelle Schmidlin; Wenwu Zhai; Colin Solomon; John Balmes
Journal:  Am J Respir Crit Care Med       Date:  2005-06-03       Impact factor: 21.405

Review 2.  An update on exercise-induced bronchoconstriction with and without asthma.

Authors:  Chris Randolph
Journal:  Curr Allergy Asthma Rep       Date:  2009-11       Impact factor: 4.806

3.  Functional and pathologic consequences of a 52-week exposure to 0.5 PPM ozone followed by a clean air recovery period.

Authors:  K B Gross; H J White
Journal:  Lung       Date:  1987       Impact factor: 2.584

4.  TRPA1 mediates changes in heart rate variability and cardiac mechanical function in mice exposed to acrolein.

Authors:  Nicole Kurhanewicz; Rachel McIntosh-Kastrinsky; Haiyan Tong; Allen Ledbetter; Leon Walsh; Aimen Farraj; Mehdi Hazari
Journal:  Toxicol Appl Pharmacol       Date:  2016-10-13       Impact factor: 4.219

Review 5.  Effects of ozone exposure at ambient air pollution episode levels on exercise performance.

Authors:  W C Adams
Journal:  Sports Med       Date:  1987 Nov-Dec       Impact factor: 11.136

6.  Response of macaque bronchiolar epithelium to ambient concentrations of ozone.

Authors:  J R Harkema; C G Plopper; D M Hyde; J A St George; D W Wilson; D L Dungworth
Journal:  Am J Pathol       Date:  1993-09       Impact factor: 4.307

7.  Exposure-effect relationship of selected pulmonary function measurements in subjects exposed to ozone.

Authors:  J Kagawa
Journal:  Int Arch Occup Environ Health       Date:  1984       Impact factor: 3.015

8.  Acute pulmonary function response to ozone in young adults as a function of body mass index.

Authors:  William D Bennett; Milan J Hazucha; Lawrence J Folinsbee; Philip A Bromberg; Grace E Kissling; Stephanie J London
Journal:  Inhal Toxicol       Date:  2007-11       Impact factor: 2.724

9.  Effects of cyclosporine A on ozone-induced pulmonary lesion formation: pharmacologic elimination of the T-lymphocyte regulatory response.

Authors:  M R Bleavins; N E Sargent; D Dziedzic
Journal:  Arch Environ Contam Toxicol       Date:  1995-02       Impact factor: 2.804

10.  Association of ambient ozone exposure with airway inflammation and allergy in adults with asthma.

Authors:  Sumita B Khatri; Fernando C Holguin; P Barry Ryan; David Mannino; Serpil C Erzurum; W Gerald Teague
Journal:  J Asthma       Date:  2009-10       Impact factor: 2.515

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.